Human IgE Isotype Control [Alexa Fluor® 647]
Novus Biologicals, part of Bio-Techne | Catalog # DDXCH07A647-100
Key Product Details
Species Reactivity
Human
Applications
Flow (Cell Surface), Flow (Intracellular), Flow Cytometry, Immunofluorescence
Label
Alexa Fluor 647 (Excitation = 650 nm, Emission = 668 nm)
Antibody Source
Polyclonal Human IgE
Concentration
Please contact technical services for concentration.
Product Specifications
Clonality
Polyclonal
Host
Human
Isotype
IgE
Description
This Human IgE immunoglobulin is useful as an isotype control for Human IgE antibody.
Applications for Human IgE Isotype Control [Alexa Fluor® 647]
Application
Recommended Usage
Flow (Cell Surface)
1:10 - 1:1000
Flow (Intracellular)
1:10 - 1:1000
Flow Cytometry
1:10-1:1000
Immunofluorescence
1:10 - 1:500
Application Notes
Use the isotype control at the same concentration as the experimental antibody. Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Ion exchange chromatography
Formulation
PBS, 50% glycerol.
Preservative
No Preservative
Concentration
Please contact technical services for concentration.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C in the dark. Avoid freeze-thaw cycles.
Background: IgE
Long Name
Immunoglobulin E
Alternate Names
IgE, immunoglobulin heavy constant epsilon
Gene Symbol
IGHE
Additional IgE Products
Product Documents for Human IgE Isotype Control [Alexa Fluor® 647]
Product Specific Notices for Human IgE Isotype Control [Alexa Fluor® 647]
This product is manufactured by Eurobio Scientific (formerly Dendritics) and distributed by Novus Biologicals.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Isotype Controls are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...